409 related articles for article (PubMed ID: 25542265)
21. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
Liu KG; Xie HH; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors.
Ognibene M; Cangelosi D; Morini M; Segalerba D; Bosco MC; Sementa AR; Eva A; Varesio L
PLoS One; 2017; 12(11):e0187206. PubMed ID: 29117193
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
25. High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α.
Tan JT; Prosser HC; Vanags LZ; Monger SA; Ng MK; Bursill CA
FASEB J; 2014 Jan; 28(1):206-17. PubMed ID: 24022405
[TBL] [Abstract][Full Text] [Related]
26. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
Liu LP; Ho RL; Chen GG; Lai PB
Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
[TBL] [Abstract][Full Text] [Related]
27. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
28. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
29. A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
Kato A; Ng S; Thangasamy A; Han H; Zhou W; Raeppel S; Fallon M; Guha S; Ammanamanchi S
Mol Carcinog; 2021 Nov; 60(11):734-745. PubMed ID: 34347914
[TBL] [Abstract][Full Text] [Related]
30. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
[TBL] [Abstract][Full Text] [Related]
32. Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma.
Leppänen J; Helminen O; Huhta H; Kauppila JH; Isohookana J; Haapasaari KM; Parkkila S; Saarnio J; Lehenkari PP; Karttunen TJ
World J Surg Oncol; 2018 Jul; 16(1):127. PubMed ID: 29973215
[TBL] [Abstract][Full Text] [Related]
33. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
35. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene.
Zhao T; Gao S; Wang X; Liu J; Duan Y; Yuan Z; Sheng J; Li S; Wang F; Yu M; Ren H; Hao J
PLoS One; 2012; 7(8):e43399. PubMed ID: 22952674
[TBL] [Abstract][Full Text] [Related]
37. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.
Melstrom LG; Salabat MR; Ding XZ; Strouch MJ; Grippo PJ; Mirzoeva S; Pelling JC; Bentrem DJ
J Surg Res; 2011 May; 167(2):173-81. PubMed ID: 21227456
[TBL] [Abstract][Full Text] [Related]
38. [Expression of hypoxia inducible factor-1α and insulin in pancreatic cancer and their correlation].
Wang TL; Liu T; Gou SM; Wang L; Zhou W; Wang CY
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):348-51. PubMed ID: 22883454
[TBL] [Abstract][Full Text] [Related]
39. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
40. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
